# Generalization of Extinction Learning

> **NCT01900301** · PHASE1 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 60 (actual)

## Conditions studied

- Social Anxiety Disorder

## Interventions

- **DRUG:** Scopolamine
- **DRUG:** intranasal placebo

## Key facts

- **NCT ID:** NCT01900301
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01900301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01900301, "Generalization of Extinction Learning". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01900301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*